Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-16

To be fair, just because I am a "non-holder" doesn't mean I know "nothing" about the company. I propose that I know just as much as you do. I don't think people understand the concept of "IIH phase 3 will still go ahead" you make it sound like with these approvals they can just take off where they left it and continue. Phase 3 double blinded clinical trials are not like that. You most likely have to start all over again, possibly some results may be admitted, but only if they can tick all the boxes of the next criteria, and usually once the criteria is changed, that affects the blinding, which means everything that was done so far would most likely get tossed in the bin, in my opinion.